Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q21098973> ?p ?o }
Showing triples 1 to 25 of
25
with 100 triples per page.
- Q21098973 subject Q7336348.
- Q21098973 abstract "Etelcalcetide is a D-amino peptide calcimimetic undergoing clinical evaluation for the treatment of secondary hyperparathyroidism for patients with chronic kidney disease (CKD) on hemodialysis. Etelcalcetide is administered intravenously at the end of each dialysis session. It functions by binding to and activating the calcium-sensing receptor (CaSR) in the parathyroid gland as an allosteric activator, resulting in PTH reduction and suppression. Elevated PTH is often observe in patients with CKD.On August 25, 2015 Amgen Inc. announced its submission of a New Drug Application to the Food and Drug Administration for etelcalcetide.".
- Q21098973 thumbnail Etelcalcetide.svg?width=300.
- Q21098973 wikiPageExternalLink index.php?title=Velcalcetide.
- Q21098973 wikiPageExternalLink velcalcetide-for-secondary-hyperparathyroidism-first-line.
- Q21098973 wikiPageWikiLink Q1368197.
- Q21098973 wikiPageWikiLink Q14860476.
- Q21098973 wikiPageWikiLink Q15321271.
- Q21098973 wikiPageWikiLink Q204711.
- Q21098973 wikiPageWikiLink Q3622611.
- Q21098973 wikiPageWikiLink Q391744.
- Q21098973 wikiPageWikiLink Q470517.
- Q21098973 wikiPageWikiLink Q5018775.
- Q21098973 wikiPageWikiLink Q650401.
- Q21098973 wikiPageWikiLink Q7336348.
- Q21098973 wikiPageWikiLink Q736715.
- Q21098973 wikiPageWikiLink Q845326.
- Q21098973 type ChemicalSubstance.
- Q21098973 type Drug.
- Q21098973 type ChemicalObject.
- Q21098973 type Thing.
- Q21098973 type Q8386.
- Q21098973 comment "Etelcalcetide is a D-amino peptide calcimimetic undergoing clinical evaluation for the treatment of secondary hyperparathyroidism for patients with chronic kidney disease (CKD) on hemodialysis. Etelcalcetide is administered intravenously at the end of each dialysis session. It functions by binding to and activating the calcium-sensing receptor (CaSR) in the parathyroid gland as an allosteric activator, resulting in PTH reduction and suppression.".
- Q21098973 label "Etelcalcetide".
- Q21098973 depiction Etelcalcetide.svg.